These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 16375923)

  • 1. Extended flexible linker structures in the complement chimaeric conjugate CR2-Ig by scattering, analytical ultracentrifugation and constrained modelling: implications for function and therapy.
    Gilbert HE; Aslam M; Guthridge JM; Holers VM; Perkins SJ
    J Mol Biol; 2006 Feb; 356(2):397-412. PubMed ID: 16375923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution structure of the complex between CR2 SCR 1-2 and C3d of human complement: an X-ray scattering and sedimentation modelling study.
    Gilbert HE; Eaton JT; Hannan JP; Holers VM; Perkins SJ
    J Mol Biol; 2005 Feb; 346(3):859-73. PubMed ID: 15713468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 15 SCR flexible extracellular domains of human complement receptor type 2 can mediate multiple ligand and antigen interactions.
    Gilbert HE; Asokan R; Holers VM; Perkins SJ
    J Mol Biol; 2006 Oct; 362(5):1132-47. PubMed ID: 16950392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The extended multidomain solution structures of the complement protein Crry and its chimeric conjugate Crry-Ig by scattering, analytical ultracentrifugation and constrained modelling: implications for function and therapy.
    Aslam M; Guthridge JM; Hack BK; Quigg RJ; Holers VM; Perkins SJ
    J Mol Biol; 2003 Jun; 329(3):525-50. PubMed ID: 12767833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended and flexible domain solution structure of the extracellular matrix protein anosmin-1 by X-ray scattering, analytical ultracentrifugation and constrained modelling.
    Hu Y; Sun Z; Eaton JT; Bouloux PM; Perkins SJ
    J Mol Biol; 2005 Jul; 350(3):553-70. PubMed ID: 15949815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling.
    Boehm MK; Woof JM; Kerr MA; Perkins SJ
    J Mol Biol; 1999 Mar; 286(5):1421-47. PubMed ID: 10064707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution structure determination of monomeric human IgA2 by X-ray and neutron scattering, analytical ultracentrifugation and constrained modelling: a comparison with monomeric human IgA1.
    Furtado PB; Whitty PW; Robertson A; Eaton JT; Almogren A; Kerr MA; Woof JM; Perkins SJ
    J Mol Biol; 2004 May; 338(5):921-41. PubMed ID: 15111057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dimeric and trimeric solution structures of the multidomain complement protein properdin by X-ray scattering, analytical ultracentrifugation and constrained modelling.
    Sun Z; Reid KB; Perkins SJ
    J Mol Biol; 2004 Nov; 343(5):1327-43. PubMed ID: 15491616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folded-back solution structure of monomeric factor H of human complement by synchrotron X-ray and neutron scattering, analytical ultracentrifugation and constrained molecular modelling.
    Aslam M; Perkins SJ
    J Mol Biol; 2001 Jun; 309(5):1117-38. PubMed ID: 11399083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semi-extended solution structure of human myeloma immunoglobulin D determined by constrained X-ray scattering.
    Sun Z; Almogren A; Furtado PB; Chowdhury B; Kerr MA; Perkins SJ
    J Mol Biol; 2005 Oct; 353(1):155-73. PubMed ID: 16157351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The partly folded back solution structure arrangement of the 30 SCR domains in human complement receptor type 1 (CR1) permits access to its C3b and C4b ligands.
    Furtado PB; Huang CY; Ihyembe D; Hammond RA; Marsh HC; Perkins SJ
    J Mol Biol; 2008 Jan; 375(1):102-18. PubMed ID: 18028942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural studies in solution of the recombinant N-terminal pair of short consensus/complement repeat domains of complement receptor type 2 (CR2/CD21) and interactions with its ligand C3dg.
    Guthridge JM; Rakstang JK; Young KA; Hinshelwood J; Aslam M; Robertson A; Gipson MG; Sarrias MR; Moore WT; Meagher M; Karp D; Lambris JD; Perkins SJ; Holers VM
    Biochemistry; 2001 May; 40(20):5931-41. PubMed ID: 11352728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification, properties and extended solution structure of the complex formed between human immunoglobulin A1 and human serum albumin by scattering and ultracentrifugation.
    Almogren A; Furtado PB; Sun Z; Perkins SJ; Kerr MA
    J Mol Biol; 2006 Feb; 356(2):413-31. PubMed ID: 16376934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The solution structure of human coagulation factor VIIa in its complex with tissue factor is similar to free factor VIIa: a study of a heterodimeric receptor-ligand complex by X-ray and neutron scattering and computational modeling.
    Ashton AW; Boehm MK; Johnson DJ; Kemball-Cook G; Perkins SJ
    Biochemistry; 1998 Jun; 37(22):8208-17. PubMed ID: 9609717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of C3dg binding to a recess formed between short consensus repeats 1 and 2 of complement receptor type 2 (CR2; CD21).
    Prodinger WM; Schwendinger MG; Schoch J; Köchle M; Larcher C; Dierich MP
    J Immunol; 1998 Nov; 161(9):4604-10. PubMed ID: 9794388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analyses reveal that the staphylococcal immune evasion molecule Sbi and complement receptor 2 (CR2) share overlapping contact residues on C3d: implications for the controversy regarding the CR2/C3d cocrystal structure.
    Isenman DE; Leung E; Mackay JD; Bagby S; van den Elsen JM
    J Immunol; 2010 Feb; 184(4):1946-55. PubMed ID: 20083651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of antibody-dependent mechanisms of tumor cell lysis by a targeted activator of complement.
    Imai M; Ohta R; Varela JC; Song H; Tomlinson S
    Cancer Res; 2007 Oct; 67(19):9535-41. PubMed ID: 17909064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible dimer formation and stability of the anti-tumour single-chain Fv antibody MFE-23 by neutron scattering, analytical ultracentrifugation, and NMR and FT-IR spectroscopy.
    Lee YC; Boehm MK; Chester KA; Begent RH; Perkins SJ
    J Mol Biol; 2002 Jun; 320(1):107-27. PubMed ID: 12079338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solution structure of the complex formed between human complement C3d and full-length complement receptor type 2.
    Li K; Okemefuna AI; Gor J; Hannan JP; Asokan R; Holers VM; Perkins SJ
    J Mol Biol; 2008 Dec; 384(1):137-50. PubMed ID: 18804116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution structure of TT30, a novel complement therapeutic agent, provides insight into its joint binding to complement C3b and C3d.
    Li K; Gor J; Holers VM; Storek MJ; Perkins SJ
    J Mol Biol; 2012 May; 418(3-4):248-63. PubMed ID: 22387467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.